Yanin Chávarri-Guerra

Author

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán ORCID

Also Known As

Chavarri-Guerra, Yanin, Y Chavarri-Guerra, Y Chávarri-Guerra, Y. Chavarri-Guerra, Yanin Chavarri Guerra, Yanin Chavarri-Guerra, Yanin Chavarri‐Guerra, Yanin Chávarri-Guerra, Yanin Chávarri-Guerra

143

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Massachusetts General Hospital Instituto Nacional de Cancerología City of Hope Hospital de Clínicas de Porto Alegre

About

Yanin Chávarri-Guerra is an author at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	1.5K
2	Public Health	7	7	1.1K
3	Epidemiology	2	2	98
4	Family Medicine	1	1	22
5	Gastroenterology	1	1	35

Yanin Chávarri-Guerra

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Challenges to effective cancer control in China, India, and Russia Paul E. Goss, Kathrin Strasser‐Weippl, Brittany Bychkovsky, The Lancet Oncology MedicineGlobal HealthCancer ManagementCancer PreventionBreast Cancer	2014	497
Planning cancer control in Latin America and the Caribbean Paul E. Goss, Brittany Lee, Tanja Badovinac-Črnjević, The Lancet Oncology Preventive MedicineMedicineGlobal HealthEpidemiology Of CancerCancer Prevention	2013	496
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial Paul E. Goss, Ian E. Smith, Joyce O’Shaughnessy, The Lancet Oncology Breast OncologyAdjuvant LapatinibMedicineBreast CancerCancer Treatment	2012	130
Breast Cancer in Young Women in Latin America: An Unmet, Growing Burden Cynthia Villarreal‐Garza, Christian Águila, Maria Cristina Magallanes-Hoyos, The Oncologist	2013	127
Outcomes of Breast Cancer in Brazil Related to Health Care Coverage: A Retrospective Cohort Study Pedro Emanuel Rubini Liedke, Dianne M. Finkelstein, Jackie Szymonifka, Cancer Epidemiology Biomarkers & Prevention	2013	110
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole Paul E. Goss, J. N. Ingle, Silvana Martino, Annals of Oncology Breast OncologyOncologyClinical TrialsGynecologyBreast Cancer	2012	92
Providing Supportive and Palliative Care Using Telemedicine for Patients with Advanced Cancer During the COVID-19 Pandemic in Mexico Yanin Chávarri-Guerra, Wendy Alicia Ramos-López, Alfredo Covarrubias‐Gómez, The Oncologist	2020	78
Breast Cancer in Young Women in Latin America: An Unmet, Growing Burden Cynthia Villarreal‐Garza, Christian Águila, Maria Cristina Magallanes-Hoyos, The Oncologist Breast OncologyEpidemiology Of CancerLatin AmericaBc IncidenceCancer Risk Factors	2013	72
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline Nadine Tung, Charité Ricker, Hans Messersmith, Journal of Clinical Oncology	2024	67
Tumor-Associated Neutrophils in Breast Cancer Subtypes Enrique Soto‐Pérez‐de‐Celis, Yanin Chávarri-Guerra, Eucario León-Rodrı́guez, PubMed Breast OncologyPathologyCancer BiologyBreast Cancer SubtypeTumor Biology	2017	56

Page 1